- Retraction Note
- Open Access
Retraction Note to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer
Molecular Cancer volume 16, Article number: 121 (2017)
The original article was published in Molecular Cancer 2013 12:34
This article  has been retracted by the authors after they discovered an error in the data. The authors recently performed Short Tandem Repeat (STR) analysis on all of their cell lines and discovered that the cell clone T47D:A18/PKCα is in fact MCF-7/PKCα. They have verified this using next generation sequencing of the p53 mutation that is a hallmark of T47D cells. All other cell lines reported in this article are as originally described. As a result of this error, parts of the article are inaccurate which affects the article’s conclusions. The authors will be given the opportunity to resubmit their corrected data.
Perez White B, Molloy ME, Zhao H, Zhang Y, Tonetti DA. Extranuclear ERα is associated with regression of T47D PKCα-overexpressing. Mol Cancer. 2013 May 1;12:34.
The online version of the original article can be found under doi:10.1186/1476-4598-12-34
About this article
Cite this article
White, B.P., Molloy, M.E., Zhao, H. et al. Retraction Note to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer. Mol Cancer 16, 121 (2017) doi:10.1186/s12943-017-0697-5